(S)-3-(4-Boronophenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid
98%
- Product Code: 57157
CAS:
119771-23-2
| Molecular Weight: | 309.12 g./mol | Molecular Formula: | C₁₄H₂₀BNO₆ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD01860642 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, store under inert gas |
Product Description:
This chemical is primarily used in the field of medicinal chemistry and drug development, particularly in the synthesis of boron-containing compounds. Its boronic acid functional group makes it valuable in the design of protease inhibitors, which are crucial in treating diseases like cancer, HIV, and hypertension. The compound is also employed in Suzuki-Miyaura cross-coupling reactions, a widely used method in organic synthesis to create complex molecules for pharmaceuticals. Additionally, its tert-butoxycarbonyl (Boc) protecting group allows for selective reactions, making it a versatile intermediate in peptide synthesis. Its applications extend to the development of boron neutron capture therapy (BNCT) agents, a targeted cancer treatment approach.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | €23.98 |
+
-
|
| 5.000 | 10-20 days | €73.37 |
+
-
|
| 25.000 | 10-20 days | €264.74 |
+
-
|
(S)-3-(4-Boronophenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid
This chemical is primarily used in the field of medicinal chemistry and drug development, particularly in the synthesis of boron-containing compounds. Its boronic acid functional group makes it valuable in the design of protease inhibitors, which are crucial in treating diseases like cancer, HIV, and hypertension. The compound is also employed in Suzuki-Miyaura cross-coupling reactions, a widely used method in organic synthesis to create complex molecules for pharmaceuticals. Additionally, its tert-butoxycarbonyl (Boc) protecting group allows for selective reactions, making it a versatile intermediate in peptide synthesis. Its applications extend to the development of boron neutron capture therapy (BNCT) agents, a targeted cancer treatment approach.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :